• Course
  • ELU

1 hour


Diabetes in renal dysfunction (kidney disease)

Learning outcomes

After completing this module, you should:

  • Understand the rationale of selecting anti-diabetic agents for glycaemic control in patients with renal impairment
  • Know about the concept of new-onset diabetes after transplant (NODAT) and its management.


Alka Jha

Peer reviewed by:

Christos Kazazis


Accreditor credit Accreditation statement
BMJ Learning 1 credit, 1:00 hour BMJ Learning has assigned one hour of credit to this module